Children’s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina, Kyle S. Smith, Catherine A. Billups, Peter C. Burger, Leanne M. Embry, Patricia L. Cullen, Kristina K. Hardy, Scott L. Pomeroy, Johnnie K. Bass, Stephanie M. Perkins, Thomas E. Merchant, Paul D. Colte, Thomas J. Fitzgerald, Timothy N. Booth, Joel M. Cherlow, Karin M. Muraszko, Jennifer Hadley, Rahul KumarYuanyuan Han, Nancy J. Tarbell, Maryam Fouladi, Ian F. Pollack, Roger J. Packer, Yimei Li, Amar Gajjar, Paul A. Northcott
Dive into the research topics of 'Children’s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma'. Together they form a unique fingerprint.